Acquisition by Wilderotter Mary Agnes of 2077 shares of Sana Biotechnology subject to Rule 16b-3

SANA Stock  USD 1.65  0.05  3.12%   
About 59% of all Sana Biotechnology's investors are looking to take a long position. The analysis of the overall investor sentiment regarding Sana Biotechnology suggests that some traders are interested. The current market sentiment, together with Sana Biotechnology's historical and current headlines, can help investors time the market. In addition, many technical investors use Sana Biotechnology stock news signals to limit their universe of possible portfolio assets.
  
Filed transaction by Sana Biotechnology Inc director. Grant, award or other acquisition pursuant to Rule 16b-3(d)

Read at macroaxis.com
Sana insider trading alert for grant of common stock by Wilderotter Mary Agnes, the corporate stakeholder, on 6th of October 2023. This event was filed by Sana Biotechnology Inc with SEC on 2023-10-06. Statement of changes in beneficial ownership - SEC Form 4

Cash Flow Correlation

Sana Biotechnology's cash-flow correlation analysis can be used to evaluate the unsystematic risk during the given period. It also helps investors identify the Sana Biotechnology's relationships between the major components of the statement of changes in financial position and other commonly used cash-related accounts. When such correlations are discovered, they may help managers and analysts to enhance performance or determine appealing investment opportunities.
Click cells to compare fundamentals

Sana Biotechnology Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Sana Biotechnology can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Sana Biotechnology Fundamental Analysis

We analyze Sana Biotechnology's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Sana Biotechnology using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Sana Biotechnology based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Shares Owned By Insiders

Shares Owned By Insiders Comparative Analysis

Sana Biotechnology is currently under evaluation in shares owned by insiders category among its peers. Shares Owned by Insiders show the percentage of outstanding shares owned by insiders (such as principal officers or members of the board of directors) or private individuals and entities with over 5% of the total shares outstanding. Company executives or private individuals with access to insider information share information about a firm's operations that is not available to the general public.

Sana Biotechnology Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Sana Biotechnology stock to make a market-neutral strategy. Peer analysis of Sana Biotechnology could also be used in its relative valuation, which is a method of valuing Sana Biotechnology by comparing valuation metrics with similar companies.

Peers

Sana Biotechnology Related Equities

GBIOGeneration Bio   10.19   
0%
100.0%
NKTXNkarta   7.73   
0%
75.0%
GLUEMonte Rosa   6.45   
0%
63.0%
CGEMCullinan Oncology   5.94   
0%
58.0%
OLMAOlema Pharmaceuticals   5.35   
0%
52.0%
KYMRKymera Therapeutics   3.88   
0%
38.0%
DAWNDay One   2.65   
0%
26.0%
ZNTLZentalis Pharmaceuticals   2.39   
0%
23.0%
AMLXAmylyx Pharmaceuticals   2.27   
0%
22.0%
RVMDRevolution Medicines   1.78   
0%
17.0%
BPMCBlueprint Medicines   1.36   
0%
13.0%
APLSApellis Pharmaceuticals   0.21   
0%
2.0%
TERNTerns Pharmaceuticals   3.14   
30.0%
0%
XFORX4 Pharmaceuticals   4.69   
46.0%
0%
LYELLyell Immunopharma   4.69   
46.0%
0%
HOOKHookipa Pharma   5.61   
55.0%
0%

Complementary Tools for Sana Stock analysis

When running Sana Biotechnology's price analysis, check to measure Sana Biotechnology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Sana Biotechnology is operating at the current time. Most of Sana Biotechnology's value examination focuses on studying past and present price action to predict the probability of Sana Biotechnology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Sana Biotechnology's price. Additionally, you may evaluate how the addition of Sana Biotechnology to your portfolios can decrease your overall portfolio volatility.
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.